Skip to main content
logo
Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
4.390
+0.390 (9.75%)
At close: Aug 19, 2026, 4:00 PM EDT
4.190
-0.200 (-4.56%)
After-hours: Aug 19, 2026, 8:00 PM EDT

APUS Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-5.15-1.28-0.75-0.64-1.02
Net Income
-5.16-1.39-0.78-0.67-1.03
Earnings Per Share
-0.53-0.18-0.17-0.17-0.27
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.9900.410.010.17
Total Debt
0.50.670.270.680.4
Net Cash (Debt)
6.49-0.670.14-0.68-0.23
Net Cash Growth
-----
Net Cash Per Share
0.67-0.080.03-0.18-0.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.21-0.73-0.63-0.45-0.82
Free Cash Flow
-5.21-0.73-0.63-0.45-0.82
Free Cash Flow Growth
-----